| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mulacek Phil E | Director, 10%+ Owner | 25025 I 45 NORTH, SUITE 420, THE WOODLANDS | /s/ Phil E. Mulacek | 07 Nov 2025 | 0001670677 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EP | Convertible Note Due 2027 | Award | $4M | $4M | 24 Sep 2025 | Common Stock | 463K | $4.32 | Direct | F1 | |||
| transaction | EP | Common Stock Warrant (Right to Buy) | Award | $0 | +139K | $0.00 | 139K | 24 Sep 2025 | Common Stock | 139K | $4.32 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The Convertible Note was amended on November 5, 2025 to increase the conversion price from $4.27 to $4.32, and to provide that the conversion price of $4.32 only applies to the first $2,000,000 already advanced under the Convertible Note. Excludes shares issuable at the election of the Reporting Person upon conversion of any additional advances under the Convertible Note based upon a floating conversion price as set forth in the Convertible Note, as amended. |
| F2 | The Warrant was amended on November 5, 2025 to (a) increase the exercise price of the Warrant from $4.27 to $4.32 and (b) reduce the number of shares of common stock of the Issuer underlying the Warrant from 281,030 to 138,889. |
| F3 | The Warrant becomes exercisable on the date the NYSE American stock exchange approves a supplemental listing application relating to the shares of common stock of the Issuer underlying the Warrant. |